TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for March 2019

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for March 2019.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 19 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.001,17901,179
Mar 19 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS16.631,17919,6011,3882.6 K to 1.4 K (-45.93 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.001,17902,5671.4 K to 2.6 K (+84.94 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.008720874
Mar 19 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS16.643205,3269,0029.3 K to 9 K (-3.43 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.0087209,3228.5 K to 9.3 K (+10.32 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.001,29701,297
Mar 19 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS16.641,29721,58801.3 K to 0 (-100.00 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.001,29701,2970 to 1.3 K
Mar 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseM0.002,35802,359
Mar 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...SellS16.432,35838,7422,9745.3 K to 3 K (-44.22 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...BuyM0.002,35805,3323 K to 5.3 K (+79.29 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseM0.006600661
Mar 19 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...SellS16.632303,82412,76013 K to 12.8 K (-1.77 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...BuyM0.00660012,99012.3 K to 13 K (+5.35 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.009430944
Mar 19 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS16.6394315,6770943 to 0 (-100.00 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.0094309430 to 943
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.002650266
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.007470748
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS16.63931,54616,75016.8 K to 16.8 K (-0.55 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS16.632634,37216,84317.1 K to 16.8 K (-1.54 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.00265017,10616.8 K to 17.1 K (+1.57 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.00747016,84116.1 K to 16.8 K (+4.64 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,17901,179
Mar 19 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS16.6363210,5079,1499.8 K to 9.1 K (-6.46 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,17909,7818.6 K to 9.8 K (+13.71 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseM0.002,44400
Mar 14 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...SellS15.822,44438,6642,9745.4 K to 3 K (-45.11 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...BuyM0.002,44405,4183 K to 5.4 K (+82.18 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.0073800
Mar 14 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS15.6773811,5681,3882.1 K to 1.4 K (-34.71 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.0073802,1261.4 K to 2.1 K (+53.17 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.0088300
Mar 14 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS15.693255,0998,4508.8 K to 8.5 K (-3.70 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.0088308,7757.9 K to 8.8 K (+11.19 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.0095300
Mar 14 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS15.6795314,9380953 to 0 (-100.00 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.0095309530 to 953
Mar 14 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,19100
Mar 14 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS15.6764710,1428,6029.2 K to 8.6 K (-7.00 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,19109,2498.1 K to 9.2 K (+14.78 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.0071500
Mar 14 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS15.6971511,2180715 to 0 (-100.00 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.0071507150 to 715
Mar 06 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseA0.0041,791041,791
Mar 06 2019TEVATEVA PHARMACEUTICA ...Schultz KarePresident and CEOOption ExerciseA0.00179,1040179,104
Mar 06 2019TEVATEVA PHARMACEUTICA ...Sabag MarkEVP, Global Human R ...Option ExerciseA0.0047,761047,761
Mar 06 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseA0.0056,716056,716
Mar 06 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseA0.0038,805038,805
Mar 06 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseA0.0050,746050,746
Mar 06 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseA0.0019,321019,321
Mar 06 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseA0.0056,716056,716
Mar 06 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseA0.0041,791041,791
Mar 06 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...Option ExerciseA0.0074,626074,626
Mar 06 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseA0.0047,761047,761
Mar 06 2019TEVATEVA PHARMACEUTICA ...Codner Iris BeckEVP Global Brand&Co ...Option ExerciseA0.0026,865026,865
Mar 05 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.001,39902,799
Mar 05 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS16.885128,6457,8928.4 K to 7.9 K (-6.09 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.001,39908,4047 K to 8.4 K (+19.97 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.001,16602,332
Mar 05 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS16.881,16619,6861,3882.6 K to 1.4 K (-45.65 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.001,16602,5541.4 K to 2.6 K (+84.01 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseM0.001,04902,099
Mar 05 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...SellS16.883636,12912,33012.7 K to 12.3 K (-2.86 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...BuyM0.001,049012,69311.6 K to 12.7 K (+9.01 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.002,94108,823
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.001,16602,332
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS16.881,16619,68601.2 K to 0 (-100.00 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS16.882,94149,6541,1664.1 K to 1.2 K (-71.61 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.001,16604,1072.9 K to 4.1 K (+39.65 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.002,94102,9410 to 2.9 K
Mar 05 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.001,16500
Mar 05 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS16.884096,90516,09416.5 K to 16.1 K (-2.48 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.001,165016,50315.3 K to 16.5 K (+7.60 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,39902,799
Mar 05 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS16.8860610,2318,0588.7 K to 8.1 K (-6.99 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,39908,6647.3 K to 8.7 K (+19.26 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.002,09804,199
Mar 05 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS16.882,09835,42302.1 K to 0 (-100.00 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.002,09802,0980 to 2.1 K

Contact us | Follow us on Twitter